Urine alkalinization dramatically improves MTX and 7-OH-MTX solubility and excretion reducing medication toxicities (Howard et al
Upregulation of Human Autophagy-Initiation Kinase Ulk1 by Tumor Suppressor P53 Contributes to DNA-Damage-Induced Cell Death
Compounded semaglutide contains the same active ingredient as name-brand versions, and while large-scale clinical trials have not been conducted due the relatively recent adoption of GLP-1 medications, many patients report positive results
The LEADER trial (liraglutide) and SUSTAIN-6 trial (semaglutide) demonstrated cardiovascular risk reduction over multi-year follow-up periods (approximately 3.8 years and 2.1 years, respectively)
MASLD and chronic HCV infection share similar pathological features, such as insulin resistance and risk factors such as T2DM
While the clinical research surrounding N-Acetyl-L-Cysteine is highly encouraging, it is important to maintain a realistic outlook